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TGF-β receptor implicated in vascular 
disease
Aneurysm syndromes with a continuum of clinical features 
have recently been found to be associated with mutations in 
the transforming growth factor-β receptors 1 and 2 (TGF-β1 
and TGF-β2). To explore the clinical presentation of these syn-
dromes, Loeys and colleagues studied patients with Loeys-Dietz 
syndrome, which is characterized by severe generalized arterial 
tortuosity, vascular aneurysm, and aortic dissection. For both 
the type I and type II (Ehlers-Danlos) Loeys-Dietz syndromes, 
mutations were identified in either TGF-β1 or TGF-β2 in 42 
of the 52 probands. All but two of these mutations were mis-
sense mutations affecting the threonine kinase domains of the 
receptors. Phenotypic differences were not observed between 
subjects with TGF-β1 mutations and subjects with TGF-β2 
mutations. Differences in natural histories and clinical out-
comes between the groups were intriguing. Thus, genotyping of 
patients presenting with features of this disease is warranted for 
determining treatment. (N Engl J Med 355:788–98, 2006)
Coupling of tumorigenesis and 
inflammation
Early studies conferred angiogenesis capabilities to tumors; 
however, recent studies have shown that dominant oncogenes 
such as Myc and Ras directly command angiogenesis upon 
activation. Shchors and colleagues recently employed a switch-
able orthotopic transgenic mouse model of Myc activation in 
pancreatic β cells. In this system, islet endothelial cells quickly 
began to proliferate following Myc activation. Myc-induced 
angiogenesis demonstrated typical tumor vasculature, and, 
concordantly, Myc activation in β cells induced production and 
subcellular redistribution of vascular remodeling factor VEGF A. 
VEGF A release is triggered by matrix metalloproteases (MMPs) 
although none of the obvious MMPs was directly affected by 
Myc activation. Interleukin 1β (IL-1β), a cytokine involved in 
inflammation and MMP activation, was shown to be induced 
early following Myc activation but preceding VEGF A release. 
Inhibition of IL-1β prevented release of VEGF A and limited 
endothelial cell proliferation in islets. These findings emphasize 
the fact that pathways that program tumorigenesis and inflam-
mation are intertwined. (Genes Dev 20:2527–38, 2006)
Sensing the matrix
Understanding the differentiation of stem cells is paramount for 
developing regenerative therapies for cardiomyoplasty, muscu-
lar dystrophy, and neuroplasty. Mesenchymal stem cells (MSCs) 
differentiate into anchorage-dependent cell types, including 
neurons, myoblasts, and osteoblasts, at least in part by sensing 
the matrix elasticity and translating this information for gene 
transcription. Utilizing a collagen-coated gel system to mimic 
brain, muscle, and bone matrices, Engler and colleagues 
recently demonstrated that the matrix stiffness directs the differ-
entiation of MSCs. Furthermore, nonmuscle myosin II is critical 
for elasticity-directed lineage determination. Induction media 
was less effective than the matrix stiffness in inducing markers 
and morphology of differentiation. Interestingly, MSCs that were 
cultured on one type of matrix for several weeks were strongly 
committed to their original specification even in the presence 
of additional induction media for another cell type. Thus, MSC 
differentiation is dramatically influenced by the physical prop-
erties of the microenvironment. (Cell 126:677–89, 2006)
New melanoma loci found
Nevi density (ND) is the best predictor of cutaneous malignant 
melanoma. The density of these benign melanocyte tumors is 
heritable and increases until a maximum is achieved at around 
age 35 followed by a decline in density with age. Previous link-
age analysis of families with multiple melanomas implicated the 
chromosomal region 9p21, which contains two tumor suppres-
sor genes (CDKN2A and CDKN2B) involved in cell-cycle arrest. 
Falchi and colleagues performed a genome-wide linkage analysis 
search for ND on 1,730 twin females. In addition to confirming 
linkage signals on chromosome 9, a novel quantitative trait locus 
was identified on chromosome 5q31–32, specifically in twins 
aged 35 years or younger. This chromosomal region harbors two 
candidate tumor suppressor genes—the α-catenin gene CTNNA1 
and the protocadherin gene PCDHB11—along with many other 
genes. These analyses not only identified a new chromosomal 
locus but also provided a genetic link between nevogenesis and 
melanoma. (Hum Mol Genet 15:2975–9, 2006)
No safe UV
UVB radiation is readily absorbed by DNA and exerts a geno-
toxic effect by generating bipyrimidine DNA photoproducts. 
UVA radiation, which is more abundant and of greater impor-
tance for melanoma formation, induces a mutagenic effect by 
mechanisms that are not well understood because these wave-
lengths are poorly absorbed by DNA. Previous studies in cul-
tured cells indicated that UVA radiation induced cyclobutane 
pyrimidine dimers (CPDs) in DNA. Mouret and colleagues 
recently demonstrated that CPDs are the predominant lesions 
in human skin following UVA exposure. Although damage by 
UVA radiation has been attributed to oxidative stress, CPDs 
were found to be produced at higher frequencies than oxida-
tive lesions. Thus, initiation of skin cancers by UVA and UVB 
radiation may result from the same type of DNA damage. 
Persistence and limited repair of the UVA-induced lesions in 
human skin cells underscores the importance of protecting the 
skin from these harmful wavelengths. (Proc Natl Acad Sci USA 
103:13765–70, 2006)
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